Coe Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-7,165
Closed -$1.21M 88
2018
Q1
$1.21M Hold
7,165
1.31% 31
2017
Q4
$1.17M Sell
7,165
-795
-10% -$143K 1.24% 31
2017
Q3
$1.63M Sell
7,960
-80
-1% -$18.6K 1.69% 22
2017
Q2
$1.95M Buy
8,040
+125
+2% +$29.4K 2.22% 11
2017
Q1
$1.89M Buy
+7,915
New +$1.84M 2.28% 12
2016
Q4
Sell
-6,830
Closed -$1.57M 186
2016
Q3
$1.57M Sell
6,830
-3,460
-34% -$846K 0.51% 70
2016
Q2
$2.38M Buy
10,290
+4,195
+69% +$967K 0.82% 32
2016
Q1
$1.63M Buy
6,095
+330
+6% +$94.5K 0.52% 63
2015
Q4
$1.8M Sell
5,765
-335
-5% -$99.7K 0.72% 43
2015
Q3
$1.66M Sell
6,100
-14,035
-70% -$4.31M 0.61% 48
2015
Q2
$6.11M Buy
20,135
+18,135
+907% +$5.41M 2.22% 1
2015
Q1
$595K Buy
+2,000
New +$570K 0.24% 121

Other funds holding AGN

Coe Capital Management's AGN Position: Q2 2018 in Review

Coe Capital Management sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 7,165 shares — an estimated $1.21M sold.

Coe Capital Management first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $6.11M in Q2 2015. 1,043 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Coe Capital Management reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Coe Capital Management sold 7,165 Allergan plc shares in Q2 2018, an estimated $1.21M.
  • Coe Capital Management first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • Coe Capital Management's Allergan plc position peaked at $6.11M in Q2 2015.
  • 1,043 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Coe Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.